Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 274

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Cyclic antidepressants and the risk of sudden cardiac death

Ray, Wayne A., Meredith, Sarah, Thapa, Purushottam B., Hall, Kathi, Murray, Katherine T.·2004·Clinical Pharmacology & Therapeutics

Abstract

Background: Tricyclic and other related cyclic antidepressants (TCAs), used frequently for the treatment of depression and several other indications, have cardiovascular effects that may increase the risk of sudden cardiac death. We thus sought to quantify the risk of sudden cardiac death among TCA users, according to dose, as well as among users of selective serotonin reuptake inhibitors (SSRIs). Methods: We conducted a retrospective cohort study in Tennessee Medicaid, from Jan 1, 1988, through Dec 31, 1993, which included large numbers of antidepressant users and computer files describing medication use and comorbidity. The cohort included 1,282,091 person‐years of follow‐up for persons aged 15 to 84 years who were not in a nursing home and were free of life‐threatening noncardiac illness. This included 58,956 person‐years for current use of TCAs alone, 6291 person‐years for SSRIs only, and 96,220 person‐years for former use. Results: The cohort included 1487 confirmed sudden cardiac deaths occurring in the community. When compared with nonusers of antidepressants, current users of TCAs had a dose‐related increase in the risk of sudden cardiac death. Rate ratios increased from 0.97 (95% confidence interval [CI], 0.72–1.29) for doses lower than 100 mg (amitriptyline or its equivalent) to 2.53 (95% CI, 1.04–6.12) for doses of 300 mg or more (P = .03, test for dose‐response). The rate ratio for SSRIs was 0.95 (95% CI, 0.42–2.15). There was no evidence that TCA doses lower than 100 mg increased the risk of sudden cardiac death in subgroups defined by pre‐existing cardiovascular disease, female sex, age 65 years or older, or use of amitriptyline. Conclusions: Our data suggest that SSRI antidepressants and TCAs in doses of less than 100 mg (amitriptyline equivalents) did not increase the risk of sudden cardiac death. However, higher doses of TCAs were associated with increased relative risk, which suggests that such doses should be used cautiously, particularly in patients with an elevated baseline risk of sudden death. Clinical Pharmacology & Therapeutics (2004) 75, 234–241; doi: 10.1016/j.clpt.2003.09.019

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.clpt.2003.09.019

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Cited by

See all 274

Metadata

Authors
Ray, W. A., Meredith, S., Thapa, P. B., Hall, K., & Murray, K. T.
Venue
Clinical Pharmacology & Therapeutics
Publisher
Wiley
Published
2004-03
Volume
75
Issue
3
Pages
234-241
ISSN
  • 0009-9236 (ISSN-L)
  • 1532-6535
OpenAlex
W2113377040
Cited by
274
References
41
FWCI
11.98
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cyclic antidepressants and the risk of sudden cardiac death. https://app.cochat.ai/papers/10.1016/j.clpt.2003.09.019
The paper
Ray, W. A., Meredith, S., Thapa, P. B., Hall, K., & Murray, K. T. (2004). Cyclic antidepressants and the risk of sudden cardiac death. Clinical Pharmacology & Therapeutics. https://doi.org/10.1016/j.clpt.2003.09.019

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.